Obesity News

Patients with diabetes on one of several GLP-1 receptor agonists were less likely to be diagnosed with depression and anxiety compared with those not on those medications, researchers found.

Several weight management treatments greatly improved the odds of 5% or greater weight loss within a year, but only a small number of patients with obesity use them, researchers found.

PCPs should use the waist-to-hip ratio rather than BMI to evaluate obesity among Hispanic and Latino adults, according to experts.

A new direct-to-consumer health care program launched by Eli Lilly has the potential to improve access to diabetes, obesity and migraine medications in the United States.

High weekly averages of moderate to vigorous physical activity, or MVPA, were associated with a reduced risk for progression to chronic kidney disease, according to researchers.

Daily consumption of one to three servings of kimchi was associated with a decreased prevalence of obesity in men, according to a study in BMJ Open.

Two experts recently discussed situations in which ultra-long-acting insulins may be a good choice for patients with diabetes.

The dual incretin agonist tirzepatide reduced 24-hour ambulatory BP for adults with obesity-related hypertension, with the effects potentially independent of weight loss, according to data from a planned substudy of the SURMOUNT-1 trial.

Over half of patients who stopped taking liraglutide or semaglutide were able to maintain their weight for a year, according to a recent study from Epic Research.

Motivational interviewing, a weight loss intervention recommended by the AAP, showed no benefit reducing childhood obesity during a recent study, according to research published in Pediatrics.